His research focuses on the mechanisms of drug resistance in multiple myeloma. His studies in oncogenomics and cell signaling have defined mechanisms of sensitivity and resistance to both conventional and novel drugs, providing the rationale for combining various therapeutic agents to enhance antiMM activity and overcome drug resistance.